| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/23/2002 | EP1173456A1 Secreted proteins and nucleic acids encoding them |
| 01/23/2002 | EP0700445B1 Stress proteins and uses therefor |
| 01/23/2002 | CN1332803A Streptococcus antigens |
| 01/23/2002 | CN1332802A Production of recombinant monellin using methylotrophic yeast expression system |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332799A Cancer cell vaccine |
| 01/23/2002 | CN1332748A Isolated nucleic acid molecules which encodt T cell inducible factors (TIFs), proteins encoded, and uses thereof |
| 01/23/2002 | CN1332251A Production process of infections chicken cloacal bursa virus resisting monoclonal antibody |
| 01/23/2002 | CN1332240A Superoxide dismutase-4 |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/23/2002 | CN1078042C Method for production of proteins in plant fluids |
| 01/22/2002 | US6340740 An isolated polypeptide involved in modulating apoptotis; therapy for acquired immunodeficiency syndrome (aids), nervous system disorders and ischemic injury |
| 01/22/2002 | US6340668 Administering bone morphogenetic protein-11 (bmp-11) to neuronal cells effective to promote the survival of cells |
| 01/22/2002 | US6340593 Plant-optimized polynucleotides encoding approximately 15 kDa and approximately 45 kDa pesticidal proteins |
| 01/22/2002 | US6340581 Producing acetic acid by creating a gas mixture of carbon monoxide, hydrogen, and carbon dioxide in a fermentation reactor containing an anaerobic bacteria that utilizes waste gas components and recover acetic acid from the aqueous phase |
| 01/22/2002 | US6340578 High speed determination of three-dimensional structure using isotopes; polypeptide biosynthesis |
| 01/22/2002 | US6340577 Protein fragments for use in protein targeting |
| 01/22/2002 | US6340575 An isolated nucleic acid encoding a ras superfamily, rac gene, that modulates gtpase activity; cancer therapy |
| 01/22/2002 | US6340574 Regulated autocrine growth of mammalian cells |
| 01/22/2002 | US6340571 Antibodies specific for Staphylococcus aureus, and use thereof |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | CA2259962C Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/22/2002 | CA2149333C Eck receptor ligands |
| 01/22/2002 | CA2057711C Antibiotic agent |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/22/2002 | CA1341333C Amylin peptides and uses thereof |
| 01/17/2002 | WO2002004665A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors |
| 01/17/2002 | WO2002004646A1 Expression system |
| 01/17/2002 | WO2002004617A2 Novel cacao endoproteinases and their use in the production of cocoa flavour |
| 01/17/2002 | WO2002004615A1 Method for the production of hydroxylated collagen-like compounds |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
| 01/17/2002 | WO2002004607A1 Human myeloma cell line |
| 01/17/2002 | WO2002004600A2 Novel compounds |
| 01/17/2002 | WO2002004599A2 Placental protein having multiple egf-like domains |
| 01/17/2002 | WO2002004520A2 Transporters and ion channels |
| 01/17/2002 | WO2002004518A2 Human neuropeptide y-like g protein-coupled receptor |
| 01/17/2002 | WO2002004513A2 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | WO2002004512A2 Purification of human troponin i |
| 01/17/2002 | WO2002004499A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | WO2002004496A2 Fimh adhesin proteins and methods of use |
| 01/17/2002 | WO2002004495A2 Streptococcus pyogenes antigen |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004489A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/17/2002 | WO2002004487A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 01/17/2002 | WO2002004015A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/17/2002 | WO2002004007A2 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof |
| 01/17/2002 | WO2001053474A3 Flavobacterium heparinum expression system |
| 01/17/2002 | WO2001044291A3 Polynucleotid encoding the rg1 polypeptide |
| 01/17/2002 | WO2001042299A3 Hepatitis virus sentinel virus i (svi) |
| 01/17/2002 | WO2001036461A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/17/2002 | WO2001034833A3 Regulating endogenous inhibitor at atp synthase |
| 01/17/2002 | WO2001032876A3 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 01/17/2002 | WO2001032696A3 Traf family proteins |
| 01/17/2002 | WO2001029072A3 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 01/17/2002 | WO2001027290A3 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 01/17/2002 | WO2001027144A3 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 01/17/2002 | WO2001016293A3 Dna encoding the human serine protease t |
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2000078971A3 Atp binding cassette transporter protein abc1 popypeptides |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | WO2000070023A9 Novel fab fragment libraries and methods for their use |
| 01/17/2002 | WO2000068249B1 Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor |
| 01/17/2002 | WO2000060077A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 01/17/2002 | US20020007052 Point mutations; genetic engineering; hybridization |
| 01/17/2002 | US20020007046 Polypeptides for use in the diagnosis, prevention and treatment of cancer and immunological defects |
| 01/17/2002 | US20020006903 Genetic engineering |
| 01/17/2002 | US20020006649 Matrix; for use in wound healing |
| 01/17/2002 | US20020006641 Increasing production of proteins in gram-positive microorganisms |
| 01/17/2002 | US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 01/17/2002 | US20020006607 Soild supports for use in monitoring osteogenesis |
| 01/17/2002 | US20020006407 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 01/17/2002 | US20020006391 Genetic engineering |
| 01/17/2002 | US20020006379 Diagnosis of tissue damage, cancer |
| 01/17/2002 | CA2658217A1 Expression system |
| 01/17/2002 | CA2427066A1 Method for the recovery and application of human defensins as biologically active proteins for the treatment of infections and other diseases |
| 01/17/2002 | CA2415808A1 Transporters and ion channels |
| 01/17/2002 | CA2415484A1 Human myeloma cell line |
| 01/17/2002 | CA2415464A1 Method for the production of hydroxylated collagen-like compounds |
| 01/17/2002 | CA2415127A1 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | CA2414495A1 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/17/2002 | CA2414460A1 Fimh adhesin proteins and methods of use |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/17/2002 | CA2414219A1 Lipid metabolism molecules |
| 01/17/2002 | CA2413810A1 Aminoacyl trna synthetases |
| 01/17/2002 | CA2413045A1 Expression system |
| 01/17/2002 | CA2412162A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | CA2412150A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/16/2002 | EP1172373A2 Method for preparing zinc-oligopeptide easily absorbable by the human body |
| 01/16/2002 | EP1171626A1 50 human secreted proteins |
| 01/16/2002 | EP1171615A2 Cell culture process for glycoproteins |
| 01/16/2002 | EP1171614A1 Dsp-4 dual-specificity map kinase phosphatase |
| 01/16/2002 | EP1171613A1 Dsp-7 dual-specificity map kinase phosphatase |
| 01/16/2002 | EP1171604A2 Dna sequence and recombinant production of a graminae allergen |
| 01/16/2002 | EP1171602A1 Anti-angiogenic intestinal peptides, zdint5 |
| 01/16/2002 | EP1171600A2 Zalpha13: a human secreted protein |
| 01/16/2002 | EP1171599A1 Adipocyte complement related protein homolog zacrp2 |
| 01/16/2002 | EP1171595A1 13 transmembrane protein expressed in prostate cancer |
| 01/16/2002 | EP1171591A1 48 human secreted proteins |